Nate Marquardt’s suspension has been lifted by the Pennsylvania State Athletic Commission after meeting the medical requirements he failed to meet prior to “UFC on Versus 4.” Marquardt was subsequently released by the UFC for failing his prefight medical exam due to elevated levels of testosterone. The news was first reported by MMAJunkie.
Marquardt is now a free agent and has apparently entertained several offers according to his management. Both Bellator and DREAM have reportedly shown interest in the former UFC fighter.
Marquardt had been suspended indefinitely for his failure to meet PSAC’s requirements the day before “UFC on Versus 4.” Marquardt was being monitored for his use of testosterone after notifying PSAC that he was undergoing Testosterone Replacement Therapy (TRT) to treat hypogonadism.
Marquardt had previously received a conditional Theraputic Use Exemption (TUE) from the New Jersey State Athletic Commission prior to UFC 128. As part of the conditions set forth by the NJSAC, Marquardt was required to go off TRT for eight weeks following the event and undergo tests to confirm he needed TRT. Marquardt then lost that TUE after testing high the week following the time period. Marquardt admitted that he took a higher than recommended dose trying to offset being off TRT for eight weeks and only having three weeks before his June 26 fight.
While Marquardt’s testosterone levels were reportedly back within normal limits by the time of the fight, it was still after the previously arranged deadline for the PSAC.
Marquardt will have to apply for a TUE and continue to provide documentation for any commission he fights for in the future but having his suspension lifted will allow him to resume a career outside the UFC.